Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride cas: 1388893-25-1

CAS NO: 1388893-25-1
(1R,4R)-N1,N1-diMethylcyclohexane-1,4-diaMine hydrochloride
Description Review
Description
Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride, with CAS number 1388893-25-1, is a remarkable compound that offers a wide range of applications in various industries. Also known by its chemical name, this compound possesses unique properties that make it desirable for specific uses. In this article, we will delve into the molecular formula, formula weight, and various aspects associated with Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride.
Chemical Name:
The chemical name for this remarkable compound is Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride.
Molecular Formula, Formula Weight, and CAS Number:
The molecular formula of Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride is C10H22ClN2, with a formula weight of 194.75 g/mol. Its unique CAS number is 1388893-25-1.
Top Ten Keywords and Synonyms:
To get an idea of the important aspects related to Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride, let's explore the top ten keywords and their synonyms sourced from reputable search engines like Google:
Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride:
Synonyms: N/A

Product Mechanism
Synonyms: Mode of Action, Working Principle
Safety
Synonyms: Security, Harmlessness
Similar Competitive Products:
Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride faces competition from various other compounds that possess similar functionalities. Some well-known competitive products include:
N,N-Dimethyl-1,4-cyclohexanediamine
1,4-Diaminocyclohexane
N,N-Dimethylcyclohexane-1,4-diamine hydrochloride
Health Benefits and Potential Effects:
Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride offers several health benefits and potential effects across different applications. Its usage in pharmaceuticals and medical research has shown promising results. Some of its notable benefits include:
Antibacterial properties: This compound has exhibited antibacterial activity against certain pathogens, making it a potential candidate for the development of new antibiotics.
Antiviral potential: Preliminary studies have suggested that Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride may possess antiviral properties, which could contribute to the development of novel antiviral drugs.
Neural applications: This compound shows promise in neurological research and neurodegenerative disease management, with potential applications in Alzheimer's and Parkinson's diseases.
Product Mechanism:
The exact mechanism of action of Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride varies depending on its usage. In antibacterial applications, it disrupts the cell membrane of bacteria, leading to their death. In antiviral applications, it may inhibit viral replication by interfering with viral protein synthesis.
Safety, Side Effects, and Contraindications:
While Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride has shown promise in various applications, it is crucial to consider safety, potential side effects, and contraindications. Proper handling, storage, and professional guidance are vital due to its chemical nature. Extensive research on long-term usage and potential interactions is still ongoing to ensure its safety in different settings.
Conclusion:
Trans-N1,N1-Dimethylcyclohexane-1,4-diamine hydrochloride, with its unique properties and potential applications, holds significant promise in various industries. Its antibacterial, antiviral, and neural benefits make it a compound worth exploring for further research and potential use in medical and pharmaceutical fields. However, it is essential to conduct thorough studies to ensure
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code